Last reviewed · How we verify
deksmedetomidine
At a glance
| Generic name | deksmedetomidine |
|---|---|
| Also known as | Precedex |
| Sponsor | Diskapi Yildirim Beyazit Education and Research Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Effect of Preoperative Dexmedetomidine and Tramadol on Sedation, Pain and Haemodynamics in Haemorrhoids Patients
- Dexmedetomidine-Propofol and Ketamine-Propofol During Upper Gastrointestinal System Sedation
- Effect of Deksmedetomidine and Remifentanil in Extubation Agitation (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- deksmedetomidine CI brief — competitive landscape report
- deksmedetomidine updates RSS · CI watch RSS
- Diskapi Yildirim Beyazit Education and Research Hospital portfolio CI